In our past study, CAN attenuated cardiomyocyte lipotoxicity through inhibition of the mTOR/HIF-1α pathway, an outcome that, in turn, resulted in the exertion of a protective effect on the diabetic heart [45]. The gene discussed is MTOR; the disease is Crouzon syndrome-acanthosis nigricans syndrome.